Older HIV-infected Adults and Drug Interactions: French Cross-sectional Study

Drug interactions between antiretroviral drugs and concomitants drugs and between antiretroviral need to be studied HIV-population is ageing. The referential of interactions is the Liverpool base.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infections Blood-Borne Infections Communicable Diseases Genital Diseases Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

66 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Filters in the French social security system database, 2016 :

Code of Pathology "Human Immunodeficiency Virus (HIV) infection" Age ≥ 65 years
Treatment with an antiretroviral between January 1, 2016 and December 31, 2016

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women over than 65 years with an HIV infection and insured at the French Primary Health Insurance fund

No exclusion Criteria

Treatment and study plan

Primary outcomes

frequency of major drug-drug interactions

Time frame: between Jan, 1st 2016 and Dec, 31st 2016

MDDI between 2 drugs (ARV/ARV or ARV/non-ARV) delivered during the same period yielding to a "Do Not Coadminister" statement, according to the University of Liverpool website (www.hiv-druginteractions.org/checker).

Secondary outcomes

costs associated with major drug-drug interactions

Time frame: during 2016

The costs were defined as all reimbursed healthcare acts recorded in the SNIIRAM

Sponsors and collaborators

Lead sponsor

University Hospital, Caen

Other

Registry information

Official study title

Older HIV-infected Adults and Drug Interactions: Nationwide Cross-sectional Study Based on French National Health Insurance Databases

Acronym: POPVIH65

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Jan 31, 2018
Registry last updated: Jan 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed